DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

ArQule, Inc. (NASDAQ: ARQL)



company name or ticker

ArQule (ARQL) Jumps: Stock Rises 6.8% - Tale of the Tape

This Week in Biotech: Clinical Trials and Tribulations

The J.P. Morgan Healthcare Conference led to the release of five important clinical updates this week.

ArQule Up on Study Results - Analyst Blog

ArQule Up on Study Results - Analyst Blog

Healthcare Stocks Declining; ArQule Jumps After Data Committee Signs Off On Continued Study of Cance

Healthcare Stocks Declining; ArQule Jumps After Data Committee Signs Off On Continued Study of Cancer Medication

Sector Update: Healthcare

Benzinga's Top #PreMarket Gainers

Why ArQule Inc. Shares Surged in After-Hours Trading

ArQule shares surge 26% after updating clinical trial data for key cancer drug tivantinib.

RedHill Biopharma Sells ADS - Analyst Blog

ArQule, Inc. Enters Oversold Territory - Tale of the Tape

ArQule, Inc. Enters Oversold Territory - Tale of the Tape

Narrower-than-Expected Loss at ArQule - Analyst Blog

See More Articles...